Clinical controlled study of integrative Chinese and western medicine in treating 49 cases of SARS

Jiao Qiang; Wang Biao; Zhang Rui-lin; Wang Bao-guo; Feng Li-min; Wang Hai-jian; Luo Yan-nan; Yan Xiong; Shen Hong-qiang; Ma Ying-min; Xiong Yun; Chen Wei-heng; Ma Da; Cheng Ting; Zhou Wei

doi:10.1007/BF02838027

Your Location：

Home >

Browse articles >

Clinical controlled study of integrative Chinese and western medicine in treating 49 cases of SARS

OriginalPaper | Updated：2021-08-27

- Clinical controlled study of integrative Chinese and western medicine in treating 49 cases of SARS
- Clinical controlled study of integrative Chinese and western medicine in treating 49 cases of SARS
- 中国结合医学杂志（英文版） 2003年9卷第3期页码：175-180
- Affiliations：
  
  1. Wangjing Hospital, China Academy of Traditional Chinese Medicine,Beijing
  2. Beijing Tiantan Hospital,China
- Author bio：
- Funds：
  
  The study is supporded by The Ministry of Science and Technology of 863 Programme “The Developing the Key of Technique and Products for Preventing SARS” (No. 2003AA208101)
- DOI：10.1007/BF02838027
  中图分类号：
- 纸质出版日期：2003，
Scan for full text
Qiang, J., Biao, W., Rui-lin, Z. et al. Clinical controlled study of integrative Chinese and western medicine in treating 49 cases of SARS., Chin. J. Integr. Med. 9, 175–180 (2003). https://doi.org/10.1007/BF02838027

Jiao Qiang, Wang Biao, Zhang Rui-lin, et al. Clinical controlled study of integrative Chinese and western medicine in treating 49 cases of SARS[J]. Chinese Journal of Integrative Medicine, 2003,9(3):175-180.
Qiang, J., Biao, W., Rui-lin, Z. et al. Clinical controlled study of integrative Chinese and western medicine in treating 49 cases of SARS., Chin. J. Integr. Med. 9, 175–180 (2003). https://doi.org/10.1007/BF02838027 DOI：

Jiao Qiang, Wang Biao, Zhang Rui-lin, et al. Clinical controlled study of integrative Chinese and western medicine in treating 49 cases of SARS[J]. Chinese Journal of Integrative Medicine, 2003,9(3):175-180. DOI： 10.1007/BF02838027.

摘要

Objective: To evaluate the efficacy of integrative Chinese and western medicine (ICWM) in treating severe acute respiratory syndrome (SARS) patients.Methods: Through parallel control design

49 SARS patients were observed. Used as control

there were in the western medicine (WM) group 29 patients

who were treated with Ribavirin

Levofloxacin

Thymopentin

Azithromycin

methylprednisolone

etc.

on the basis of “Recommended Protocol for Infectious Atypical Pneumonia” (abbreviated as “Recommended Protocol”) issueed by Ministry of Health. As the treated group

there were in the ICWM 20 cases. The protocol for treatment of SARS in “Special Science and Technological Action to Prevent and Treat SARS” (abbreviated as “Special S-T Action”)

issued by Ministry of Science and Technology

together with the same WM as those for the control group.Results: (1) Time from the disease onset to the symptom improvement were 5.10±2. 83 days and 7. 62±2. 27 days in ICWM and WM group respectively

P < 0.05; (2) As to corticosteroid (CS) amount and days before reducing dosage

2 groups showed no significant difference

P > 0.05; (3) There was no significant difference in the time from disease onset to the body temperature normalization and the total amount of CS and the duration of using CS before reducing it to 80 mg between the ICWM group and the WM group; (4) The days and amounts for use CS after reducing between the ICWM group and the WM group were significantly different (P < 0. 05).Conclusion: There were obvious advantages in ICWM to treat SARS

compared with that of WM alone

especially in improving the clinical symptoms

promoting the recovery of immune function

promoting the absorption of pulmonary inflammation and reducing the dosage and duration of CS treatment.

Abstract

Objective: To evaluate the efficacy of integrative Chinese and western medicine (ICWM) in treating severe acute respiratory syndrome (SARS) patients.Methods: Through parallel control design

49 SARS patients were observed. Used as control

there were in the western medicine (WM) group 29 patients

who were treated with Ribavirin

Levofloxacin

Thymopentin

Azithromycin

methylprednisolone

etc.

on the basis of “Recommended Protocol for Infectious Atypical Pneumonia” (abbreviated as “Recommended Protocol”) issueed by Ministry of Health. As the treated group

there were in the ICWM 20 cases. The protocol for treatment of SARS in “Special Science and Technological Action to Prevent and Treat SARS” (abbreviated as “Special S-T Action”)

issued by Ministry of Science and Technology

P < 0.05; (2) As to corticosteroid (CS) amount and days before reducing dosage

2 groups showed no significant difference

compared with that of WM alone

especially in improving the clinical symptoms

promoting the recovery of immune function

promoting the absorption of pulmonary inflammation and reducing the dosage and duration of CS treatment.

关键词

Severe Acute Respiratory Syndromeintegrative Chinese and western medicine treatmentcorticosteroidClinical Study

Keywords

Severe Acute Respiratory Syndromeintegrative Chinese and western medicine treatmentcorticosteroidClinical Study

references

FULL TEXT LINK

More>

浏览量

368

Downloads

CSCD

文章被引用时，请邮件提醒。

Submit

工具集

关联资源

The characteristics and dynamic changes of X-ray chest film in 50 patients with severe acute respiratory syndrome

Applying integrative Chinese and western medicine in fighting SARS

Preliminary study on clinical efficacy of integrative Chinese and western medicine in treating severe acute respiratory syndrome

Fuzheng Huayu Capsule (扶正化瘀胶囊) in the treatment of liver fibrosis: Clinical evidence and mechanism of action

Oral herbal medicines for psoriasis: A review of clinical studies